Actively Recruiting
Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study
Led by JW Pharmaceutical · Updated on 2026-04-13
10000
Participants Needed
1
Research Sites
100 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the efficacy and safety of Pitavastatin/Ezetimibe tablets (a fixed-dose combination of Pitavastatin and Ezetimibe) in patients with dyslipidemia who also have metabolic syndrome in a real-world clinical setting. As this is an observational study, participants will be treated according to the investigator's medical judgment and routine clinical practice. The study aims to observe the changes in low-density lipoprotein cholesterol (LDL-C) levels from baseline to 24 weeks and 48 weeks of treatment. Safety will also be assessed by monitoring any adverse events occurring during the 48-week observation period.
CONDITIONS
Official Title
Efficacy and Safety of Pitavastatin/Ezetimibe in Dyslipidemia Patients With Metabolic Syndrome: An Observational Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 19 years old at the time of written informed consent
- Diagnosed with dyslipidemia and metabolic syndrome
- No lipid regulator treatment within 4 weeks prior to first visit or insufficient effect after 8 weeks of treatment at same dose
- LDL-C levels meeting cardiovascular risk group criteria at first visit or planned treatment with Pitavastatin/Ezetimibe tablets by investigator
- Voluntarily signed informed consent for study participation
You will not qualify if you...
- Contraindication to Pitavastatin/Ezetimibe tablets as specified in label precautions
- Treatment with investigational products or devices within 4 weeks prior to study or expected during study
- Considered unable to participate in study for other reasons by investigator judgment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chungnam National University Hospita
Daejeon, South Korea
Actively Recruiting
Research Team
E
EUNJU KIM
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here